新闻发布 | Z6尊龙集团中文官方网站
尊龙凯时 - 人生就是搏!
Z6尊龙
跳转到主要内容
搜索
Site Search
Mainland China
|
zh
Choose locations
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
(link is external)
Brazil |
Português
(link is external)
Canada |
English
(link is external)
Canada |
Français
(link is external)
Central America |
Español
(link is external)
Colombia |
Español
(link is external)
Mexico |
Español
(link is external)
United States |
English
(link is external)
Australia |
English
(link is external)
Bangladesh |
English
(link is external)
Hong Kong S.A.R. |
繁體中文
(link is external)
India |
English
(link is external)
Indonesia |
English
(link is external)
Japan |
日本語
(link is external)
Korea |
한국어
(link is external)
Mainland China |
中文
Malaysia |
English
(link is external)
Pakistan |
English
(link is external)
Philippines |
English
(link is external)
Singapore |
English
(link is external)
Taiwan |
繁體中文
(link is external)
Thailand |
ภาษาไทย
(link is external)
Austria |
Deutsch
(link is external)
Belgium |
Français
(link is external)
Belgium |
Nederlands
(link is external)
Bulgaria |
Български
(link is external)
Czech Republic |
Česky
(link is external)
Czech Republic |
English
(link is external)
Denmark |
Dansk
(link is external)
Estonia |
Eesti
(link is external)
Finland |
Suomalainen
(link is external)
France |
Français
(link is external)
Germany |
Deutsch
(link is external)
Greece |
Ελληνικά
(link is external)
Hungary |
Magyar
(link is external)
Ireland |
English
(link is external)
Italy |
Italiano
(link is external)
Latvia |
Latvian
(link is external)
Lithuania |
Lithuanian
(link is external)
Netherlands |
Nederlands
(link is external)
Norway |
Norsk
(link is external)
Poland |
Polski
(link is external)
Portugal |
Português
(link is external)
Romania |
Română
(link is external)
Russia |
Русский
(link is external)
Serbia |
Srpski
(link is external)
Slovakia |
Slovensky
(link is external)
Slovenia |
Slovenščina
(link is external)
Slovenia |
English
(link is external)
Spain |
Español
(link is external)
Sweden |
Svenska
(link is external)
Switzerland |
Deutsch
(link is external)
Switzerland |
Français
(link is external)
Turkey |
Türk
(link is external)
United Kingdom |
English
(link is external)
Global |
English
(link is external)
Novartis Foundation |
English
(link is external)
Egypt |
English
(link is external)
Israel |
עברית
(link is external)
Saudi Arabia |
العربية
(link is external)
South Africa |
English
(link is external)
cn
Choose locations
asia-pacific
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
(link is external)
Australia |
English
(link is external)
Austria |
Deutsch
(link is external)
Bangladesh |
English
(link is external)
Belgium |
Français
(link is external)
Belgium |
Nederlands
(link is external)
Brazil |
Português
(link is external)
Bulgaria |
Български
(link is external)
Canada |
English
(link is external)
Canada |
Français
(link is external)
Central America |
Español
(link is external)
Colombia |
Español
(link is external)
Czech Republic |
Česky
(link is external)
Czech Republic |
English
(link is external)
Denmark |
Dansk
(link is external)
Egypt |
English
(link is external)
Estonia |
Eesti
(link is external)
Finland |
Suomalainen
(link is external)
France |
Français
(link is external)
Germany |
Deutsch
(link is external)
Greece |
Ελληνικά
(link is external)
Hong Kong S.A.R. |
繁體中文
(link is external)
Hungary |
Magyar
(link is external)
India |
English
(link is external)
Indonesia |
English
(link is external)
Ireland |
English
(link is external)
Israel |
עברית
(link is external)
Italy |
Italiano
(link is external)
Japan |
日本語
(link is external)
Korea |
한국어
(link is external)
Latvia |
Latvian
(link is external)
Lithuania |
Lithuanian
(link is external)
Mainland China |
中文
Malaysia |
English
(link is external)
Mexico |
Español
(link is external)
Netherlands |
Nederlands
(link is external)
Norway |
Norsk
(link is external)
Global |
English
(link is external)
Novartis Foundation |
English
(link is external)
Pakistan |
English
(link is external)
Philippines |
English
(link is external)
Poland |
Polski
(link is external)
Portugal |
Português
(link is external)
Romania |
Română
(link is external)
Russia |
Русский
(link is external)
Saudi Arabia |
العربية
(link is external)
Serbia |
Srpski
(link is external)
Singapore |
English
(link is external)
Slovakia |
Slovensky
(link is external)
Slovenia |
Slovenščina
(link is external)
Slovenia |
English
(link is external)
South Africa |
English
(link is external)
Spain |
Español
(link is external)
Sweden |
Svenska
(link is external)
Switzerland |
Deutsch
(link is external)
Switzerland |
Français
(link is external)
Taiwan |
繁體中文
(link is external)
Thailand |
ภาษาไทย
(link is external)
Turkey |
Türk
(link is external)
United Kingdom |
English
(link is external)
United States |
English
(link is external)
菜单
关于Z6尊龙
战略
多元、平等与包容
员工和文化
我们的价值观
我们的领导层
Z6尊龙
关于Z6尊龙
患者与照护者
Z6尊龙对患者和照护者的承诺
疾病领域
临床试验
患者与照护者
Z6尊龙在中国
概览
企业责任
Z6尊龙大事记
Z6尊龙中国业务
Z6尊龙中国荣誉
Z6尊龙在中国
环境、社会和治理
道德、风险和合规
可及性
环境可持续发展
全球健康
道德行为
环境、社会和治理
新闻中心
新闻发布
专题故事
媒体联络
新闻中心
职业发展
职位搜索
人才发展
员工福利
全球荣誉
(link is external)
职业发展
首页
页眉
Z6尊龙上海园区
扎根中国，承诺中华
主页
新闻中心
新闻发布
新闻发布
Date Range
- 任意 -
In The News
Media Release
Featured News
Story
News Type Filters
Language
- 任意 -
English
French
German
开始日期
结束日期
News Archive Navigation
News Archive Navigation
全部
新闻发布
专题故事
icon
列表视图
Showing 210 results
8月 2022
Featured News
8月 31, 2022
新获批 | Z6尊龙茁乐® （奥马珠单抗）预充式注射液/在家使用制剂在华获批
7月 2022
Featured News
7月 25, 2022
2022 “健康中国行-银屑病患者至美新生公益行”项目落地
Featured News
7月 21, 2022
Z6尊龙参加世界经济论坛2022新领军者年会
Featured News
7月 15, 2022
Z6尊龙预防偏头痛创新药依瑞奈尤单抗落地粤港澳大湾区
Featured News
7月 05, 2022
可善挺®获欧盟批准用于治疗儿童关节炎疾病
6月 2022
Featured News
6月 28, 2022
Z6尊龙Tabrecta®获欧盟委员会批准 用于治疗METex14跳跃突变晚期非小细胞肺癌
Featured News
6月 24, 2022
Z6尊龙达拉非尼联合曲美替尼方案获FDA批准成为首个用于BRAF V600E突变泛瘤种治疗药物组合
Featured News
6月 13, 2022
2022 ASCO速递：Z6尊龙公布达拉非尼联合曲美替尼在BRAF V600儿童低级别脑胶质瘤患者研究的创新成绩
Featured News
6月 08, 2022
2022 ASCO速递——Ribociclib带给乳腺癌患者的总生存获益再添新证
五月 2022
Featured News
5月 31, 2022
Z6尊龙于2022 ASCO和EHA发表乳腺癌和前列腺癌最新研究和创新成果
Featured News
5月 24, 2022
Z6尊龙突破性降脂创新药Inclisiran疾速落地粤港澳大湾区
Featured News
5月 20, 2022
瑞弗兰®（艾曲泊帕乙醇胺片）治疗6-11岁儿童慢性免疫性（特发性）血小板减少症*在华获批
分页
‹
前一页
1
…
5
6
7
8
9
10
11
…
18
›
下一页
网站首页
Z6尊龙
